Eisai Co logo

4523 - Eisai Co Share Price

¥8983 -326.0  -3.5%

Last Trade - 30/07/21

Large Cap
Market Cap £16.85bn
Enterprise Value £15.97bn
Revenue £4.23bn
Position in Universe 59th / 3912
Unlock 4523 Revenue
Relative Strength (%)
1m -13.2%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -29.6%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Mar 2016 2017 2018 2019 2020 2021 2022E 2023E CAGR / Avg
547,923 539,097 600,054 642,834 695,621 645,942 699,767 735,595 +3.3%
+26.6 -28.1 +29.3 +33.6 +96.7 -68.7 +40.1 +4.59
Balance Sheet
FINANCIAL BRIEF: : For the fiscal year ended 31 March 2021, Eisai Co.,Ltd revenues decreased 7% to Y645.94B. Net income decreased65% to Y42.12B. Revenues reflect Other Business segmentdecrease of 49% to Y59.88B, Europe segment decrease of 32%to Y87.56B, Japan segment decrease of 6% to Y263.52B,America segment decrease of less than 1% to Y160.43B. Netincome also reflects Other Business segment income decreaseof 53% to Y51.49B.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for 4523
Graphical History


4523 Revenue Unlock 4523 Revenue

Net Income

4523 Net Income Unlock 4523 Revenue

Normalised EPS

4523 Normalised EPS Unlock 4523 Revenue

PE Ratio Range

4523 PE Ratio Range Unlock 4523 Revenue

Dividend Yield Range

4523 Dividend Yield Range Unlock 4523 Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
4523 EPS Forecasts Unlock 4523 Revenue
Profile Summary

Eisai Co., Ltd. is a Japan-based pharmaceutical company mainly engaged in the research and development, manufacture, sale, import and export of pharmaceuticals. The Company operates in two business segments. The Pharmaceutical segment is engaged in the research, development, manufacture and sale of pharmaceuticals for medical use, generic drugs, general medicines, among others. The segment operates in five regions including Japan, Americas (North America), China, EMEA (Europe, Middle East, Africa, Oceania), Asia and Latin America (South Korea, Taiwan, Hong Kong, India, ASEAN, Latin America). The Others segment is involved in license revenues and pharmaceutical raw materials business. The Company is also engaged in the provision of brands such as the anticancer drugs Lembima and Halaven on the nerve and oncology areas.

Last Annual March 31st, 2021
Last Interim March 31st, 2021
Incorporated December 6, 1941
Public Since September 14, 1961
No. of Shareholders: 56,561
No. of Employees: 11,237
Sector Healthcare
Industry Pharmaceuticals
Index Nikkei 225 , Nikkei 300 ,
Exchange Tokyo Stock Exchange
Shares in Issue 286,666,418
Free Float (0.0%)
Eligible for
4523 Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for 4523
Upcoming Events for 4523
Wednesday 4th August, 2021
Q1 2022 Eisai Co Ltd Earnings Release
Wednesday 4th August, 2021
Q1 2022 Eisai Co Ltd Earnings Call
Wednesday 4th August, 2021
Q1 2022 Eisai Co Ltd Earnings Call (Japanese)
Wednesday 29th September, 2021
Dividend For 4523.T - 80.0000 JPY
Monday 1st November, 2021
Q2 2022 Eisai Co Ltd Earnings Release
Frequently Asked Questions for Eisai Co
What is the Eisai Co share price?

As of 30/07/21, shares in Eisai Co are trading at ¥8983, giving the company a market capitalisation of £16.85bn. This share price information is delayed by 15 minutes.

How has the Eisai Co share price performed this year?

Shares in Eisai Co are currently trading at ¥8983 and the price has moved by 2.27% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Eisai Co price has moved by -16.27% over the past year.

What are the analyst and broker recommendations for Eisai Co?

Of the analysts with advisory recommendations for Eisai Co, there are there are currently 2 "buy" , 7 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Eisai Co is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will Eisai Co next release its financial results?

Eisai Co is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2022-03-31
What is the Eisai Co dividend yield?

The Eisai Co dividend yield is 1.78% based on the trailing twelve month period.

Does Eisai Co pay a dividend?

Last year, Eisai Co paid a total dividend of 0.160k, and it currently has a trailing dividend yield of 1.78%. Looking ahead, shares in Eisai Co are due to go ex-dividend on 2021-09-29 and the next dividend pay date is 2021-12-01.

When does Eisai Co next pay dividends?

Eisai Co are due to go ex-dividend on 2021-09-29 and the next dividend pay date is 2021-12-01. The historic dividend yield on Eisai Co shares is currently 1.78%.

How do I buy Eisai Co shares?

To buy shares in Eisai Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Eisai Co?

Shares in Eisai Co are currently trading at ¥8983, giving the company a market capitalisation of £16.85bn.

Where are Eisai Co shares listed? Where are Eisai Co shares listed?

Here are the trading details for Eisai Co:

Country of listing: Japan
Exchange: TYO
Ticker Symbol: 4523
What kind of share is Eisai Co?

Based on an overall assessment of its quality, value and momentum, Eisai Co is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Eisai Co share price forecast 2021?

Shares in Eisai Co are currently priced at ¥8983. At that level they are trading at 37.03% discount to the analyst consensus target price of 0.00.

Analysts covering Eisai Co currently have a consensus Earnings Per Share (EPS) forecast of 205.267 for the next financial year.

How can I tell whether the Eisai Co share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Eisai Co. Over the past six months, the relative strength of its shares against the market has been 21.01%. At the current price of ¥8983, shares in Eisai Co are trading at 9.53% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Eisai Co PE Ratio?

The Eisai Co PE ratio based on its reported earnings over the past 12 months is 61.3. The shares are currently trading at ¥8983.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Eisai Co?

Eisai Co's management team is headed by:

Haruo Naito - CEO
Yutaka Tsuchiya - DRC
Hideki Hayashi - DRC
Yasushi Okada - COO
Kenta Takahashi - GCN
Edward Geary - MEO
Ivan Cheung - MEO
Ryohei Yanagi - CFO
Yasuhiko Kato - CHM
Yanhui Feng - MEO
Bruce Aronson - IND
Yoshiteru Kato - DRC
Mitsuaki Tanaka - CCO
Masatomi Akana - MEO
Fumihiko Ike - IND
Who are the major shareholders of Eisai Co?

Here are the top five shareholders of Eisai Co based on the size of their shareholding:

Wellington Management Company, LLP Investment Advisor/Hedge Fund
Percentage owned: 6.88% (20.4m shares)
Nomura Asset Management Co., Ltd. Investment Advisor
Percentage owned: 6.17% (18.3m shares)
Vanguard Health Care Fund Mutual Fund
Percentage owned: 6.02% (17.9m shares)
Banks' Shareholdings Purchase Corporation Corporation
Percentage owned: 5.04% (14.9m shares)
Nippon Life Insurance Company Insurance Company
Percentage owned: 3.89% (11.5m shares)
Similar to 4523
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.